insights_auto
Zašto je NOVOB80 skočio 2,33%?
Istražite detaljnijechevron_right
NOVOB80:BKK
NOVOB80 KTB DR
1,32 THB
arrow_upward
+2,33%(+0,030) 1D
16. lis, 02:55:30 GMT+7 · THB
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za NOVOB80...
Otvori
1,28 THB
Najviša
1,30 THB
Najniža
1,27 THB
Trž. kap.
133,83 mlr.
Prosj. kol.
3,88 mil.
Količina
4,35 mil.
52-tjed. najviša
2,02 THB
52-tjed. najniža
1,12 THB
Dionice u optjecaju
3,00 mlr.
Broj djelatnika
67 tis.
Otvori
1,28 THB
Najviša
1,30 THB
Najniža
1,27 THB
Trž. kap.
133,83 mlr.
Prosj. kol.
3,88 mil.
Količina
4,35 mil.
52-tjed. najviša
2,02 THB
52-tjed. najniža
1,12 THB
Dionice u optjecaju
3,00 mlr.
Broj djelatnika
67 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Foreign Policy Journal
·
prije 10 sati
Novo Nordisk (NYSE: NVO) Stock Price May Be 63% Undervalued As Buyback And Pipeline Catalysts Mount
TradingKey
·
prije 17 sati
Novo Nordisk A/S Stock (NVO) Moved Up by 3.38% on Oct 15: What Investors Need To Know
Traders Union
·
prije 22 sata
Why is Novo Nordisk stock up 3.2% today?
Traders Union
·
prije 1 dan
Novo Nordisk stock consolidates amid seller pressure near $38.39 resistance
Profil
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark, and it became the highest valued company in Europe. Wikipedia
NOVOB80 KTB DR – informacije
Glavni izvršni direktorMaziar Mike Doustdar
Zaposlenici66,7 tis.
Osnovano1923
SjedišteBagsværd, Hovedstaden, Danska
Sektor-
Web-lokacijanovonordisk.com